You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
5 April 2024
APONTIS PHARMA enters five-year distribution and marketing agreement with Novartis for two asthma medications and raises forecast
APONTIS PHARMA AG raises forecast after entering five-year distribution and marketing agreement with Novartis for two asthma medications
28 March 2024
APONTIS PHARMA expects profitable growth again in 2024
6 February 2024
APONTIS PHARMA successfully completes performance and efficiency improvement program
9 November 2023
APONTIS PHARMA presents details of the restructuring and efficiency program – Nine-month figures for 2023 and new sales and earnings forecast for 2023 published
8 November 2023
APONTIS PHARMA AG with new forecast 2023 and details on announced restructuring program
08
May 24
Conference Call
Publication quarterly statement (call-date Q1)
13
Analysts’ Conference
17
Annual General Meeting
09
Aug 24
Publication half-yearly financial statements
Annual financial statements 2023
10 August 2023
Half-yearly financial statements 2023
30 March 2023
Annual financial statements 2022
15 April 2024
Original-Research: Apontis Pharma AG (von Montega AG): Kaufen
9 February 2024
Original-Research: APONTIS PHARMA AG (von Montega AG): Kaufen
14 November 2023
31 July 2023
12 July 2023
10 May 2023
